PolyPeptide announces results of the extraordinary general meeting of shareholders
Media releases
Baar, 26 October 2026 – PolyPeptide Group AG (“PolyPeptide”) (SIX: PPGN), a specialized global CDMO for peptide-based active pharmaceutical ingredients, announced that the shareholders approved all proposals by its board of directors (the “Board”) at today’s extraordinary general meeting of shareholders.
[…]
